Đang chuẩn bị liên kết để tải về tài liệu:
Protocol of the PANCALYZE trial: A multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies today with an urgent need for novel therapeutic strategies. Biomarker analysis helps to better understand tumor biology and might emerge as a tool to develop personalized therapies. |